期刊文献+

应用组织芯片法检测EGFR、COX-2在肺癌中的表达及生物学意义 被引量:10

Detection of EGFR and COX-2 Expression by Immunohistochemical Method on a Tissue Microarray Section in Lung Cancer and Biological Significance
下载PDF
导出
摘要 背景与目的研究表明表皮生长因子受体(epidermal growth factor receptor,EGFR)和环氧合酶-2(cy-clooxygenase-2,COX-2)在多种实体瘤中存在高表达,并且可以通过相应的信号通路调节肿瘤的生长、侵袭和转移。本研究旨在探讨EGFR和COX-2在人类肺癌组织中表达的生物学意义及相互之间的关系。方法应用组织芯片技术结合免疫组织化学SP法检测89例原发肺癌、12例淋巴结转移性肺癌、12例癌前病变(不典型腺瘤样增生)和10例正常肺组织中EGFR、COX-2蛋白的表达情况。结果EGFR在肺癌组、癌前病变组、淋巴结转移性肺癌组中的阳性表达率分别为59.6%(53/89)、41.7%(5/12)和66.7%(8/12),COX-2在上述三组中的阳性表达率分别为52.8%(47/89)、41.7%(5/12)和66.7%(8/12),均较正常组明显升高(P<0.05)。EGFR和COX-2的表达与肺癌的组织学类型、临床分期和淋巴结转移有关(P<0.05),而与组织学分级、性别、年龄无关(P>0.05)。COX-2的表达还与肺癌的大体类型有关(P<0.05)。EGFR和COX-2的表达呈正相关(P<0.01)。结论EGFR和COX-2在肺癌中的异常表达与肺癌的发生、发展和恶性程度有关,两者存在一定的协同作用。检测EGFR和COX-2的表达有助于肺癌的临床诊断和预后评估。 Background and objective Epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2),which can regulate growth,invasion and metastasis of tumor through relevant signaling pathway,have been detected in a variety of solid tumors.The aim of this study is to investigate the biological significance of EGFR and COX-2 expression in lung cancer and the relationship between them.Methods The expression of EGFR and COX-2 was detected in 89 primary lung cancer tissues,12 premaliganant lesions,12 lymph node metastases,and 10 normal lung tissues as the control by immunohistochemical method on a tissue microarray section.Results EGFR protein was detectable in 59.6%,41.7%,and 66.7% of primary lung cancer tissues,premalignant lesions and lymph node metastases,respectively; COX-2 protein was detectable in 52.8%,41.7%,and 66.7% of primary lung cancer tissues,premalignant lesions and lymph node metastases,respectively,which were significantly higher than those of the control (P0.05).The positive ratios and the levels of the expression of EGFR and COX-2 proteins were closely related to histological type,clinical stage and lymph node metastasis of lung cancer (P0.05),but not to histological grade,sex and age (P0.05).COX-2 expression was related to gross type (P0.05).A highly positive correlation was observed between EGFR and COX-2 expression (P0.01).Conclusion Overexpression of EGFR and COX-2 may play an important role in the tumorgenesis,progression and malignancy of lung cancer.Detection of EGFR and COX-2 expression might be helpful to diagnosis and prognosis of lung cancer .
出处 《中国肺癌杂志》 CAS 2010年第2期107-111,共5页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 EGFR COX-2 Lung neoplasms Epidermal growth factor receptor Cyclooxygenase-2
  • 相关文献

参考文献3

二级参考文献49

  • 1Ooi A,Kobayashi M,Mai M,Nakanishi I.Amplification of c-erbB-2 in gastric cancer:detection in formalinfixed,paraffin-embedded tissue by fluorescence in situ hybridization.Lab Invest 1998; 78:345-351.
  • 2Takehana T,Kunitomo K,Suzuki S,Kono K,Fujii H,Matsumoto Y,Ooi A.Expression of epidermal growth factor receptor in gastric carcinomas.Clin Gastroenterol Hepatol 2003; 1:438-445.
  • 3Ito Y,Takeda T,Sasaki Y,Sakon M,Yamada T,Ishiguro S,Imaoka S,Tsujimoto M,Higashiyama S,Monden M,Matsuura N.Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.Pathol Res Pract 2001; 197:95-100.
  • 4Yoshikawa D,Ojima H,Iwasaki M,Hiraoka N,Kosuge T,Kasai S,Hirohashi S,Shibata T.Clinicopathological and prognostic significance of EGFR,VEGF,and HER2 expression in cholangiocarcinoma.Br J Cancer 2008; 98:418-425.
  • 5Nehls O,Oettle H,Hartmann JT,Hofheinz RD,Hass HG,Horger MS,Koppenh(o)fer U,Hochhaus A,Stieler J,Trojan J,Gregor M,Klump B.Capecitabine plus oxaliplatin as firstline treatment in patients with advanced biliary system adenocarcinoma:a prospective multicentre phase II trial.Br J Cancer 2008; 98:309-315.
  • 6Harder J,Riecken B,Kummer O,Lohrmann C,Otto F,Usadel H,Geissler M,Opitz O,Henss H.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.Br J Cancer 2006; 95:848-852.
  • 7Voravud N,Foster CS,Gilbertson JA,Sikora K,Waxman J.Oncogene expression in cholangiocarcinoma and in normal hepatic development.Hum Pathol 1989; 20:1163-1168.
  • 8Yau TK,Sze H,Soong IS,Hioe F,Khoo US,Lee AW.HER2 overexpression of breast cancers in Hong Kong:prevalence and concordance between immunohistochemistry and insitu hybridisation assays.Hong Kong Med J 2008; 14:130-135.
  • 9Carlson RW,Moench SJ,Hammond ME,Perez EA,Burstein HJ,Allred DC,Vogel CL,Goldstein LJ,Somlo G,Gradishar WJ,Hudis CA,Jahanzeb M,Stark A,Wolff AC,Press MF,Winer EP,Paik S,Ljung BM.HER2 testing in breast cancer:NCCN Task Force report and recommendations.J Natl Compr Canc Netw 2006; 4 Suppl 3:S1-S22; quiz S23-S24.
  • 10Kobayashi M,Ooi A,Oda Y,Nakanishi I.Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas:a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed,paraffin-embedded tissues.Hum Pathol 2002; 33:21-28.

共引文献29

同被引文献106

  • 1宋懿懿,顾爱琴,韩宝惠.p21、p53和c-erbB-2在非小细胞肺癌组织中的表达及临床意义[J].上海交通大学学报(医学版),2011,31(3):295-298. 被引量:6
  • 2李榕,韩宝惠.EGFR检测在肺癌中的临床意义[J].临床肿瘤学杂志,2004,9(4):420-425. 被引量:11
  • 3宁钧宇,由江峰,裴斐,王洁良,崔湘霖,郑杰.G3BP单克隆抗体制备及G3BP在肿瘤组织中表达的检测[J].中华病理学杂志,2005,34(4):215-219. 被引量:16
  • 4童凤军.肺癌患者不同证型表皮生长因子受体表达的研究[J].浙江中医杂志,2007,42(8):446-447. 被引量:20
  • 5Koch A,Gustafsson B,Fohlin H,et al.Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry[J].Diagn Cytopathol,2011,39(3):188-193.
  • 6Tauber S,Jais A,Jeitler M,et al.Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion[J].Mol Cancer,2010,28(9):200-203.
  • 7Stokes A,Joutsa J,Ala-Aho R,et al.Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma[J].Clin Cancer Res,2010,16(7):2022-2035.
  • 8Valkovskaya N,Kayed H,Felix K,et al.ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer[J].J Cell Mol Med,2007,11(5):1162-1174.
  • 9Onguru O,Gamsizkan M,Ulutin C,et al.Cyclooxygenase-2(COX-2)expression and angiogensis in glioblastonma[J].Neuropathology,2008,28(1):29-34.
  • 10Pan MR,Hou MF,Chang HC,et al.The nonsteroidan anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells[J].Exp Biol Med(Maywood),2008,233(4):456-462.

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部